DENVER, July 13,
2023 /PRNewswire/ -- DaVita Inc. today
announced that its Board of Directors appointed a new
independent director, Wendy
Schoppert, to join the Board, effective as of July 14, 2023.
"We're pleased to welcome Wendy to DaVita's board," said
Pam Arway, independent chair of the
DaVita Inc. Board of Directors. "Her proven track record and
broad corporate and board expertise will positively impact our
governance and strategy."
Ms. Schoppert has more than 30 years of leadership experience,
including serving as Executive Vice President and Chief Financial
Officer of Sleep Number Corp. from 2011 to 2014, where she also
previously served as Chief Information Officer and led Marketing,
Digital, International, and New Channel Development. Prior to
joining Sleep Number in 2005, Ms. Schoppert led U.S. Bank's Private
Asset Management team and served as Head of Product, Marketing
& Corporate Development for U.S. Bank's Asset Management
division. She began her career in the airline industry, serving in
various financial, strategic and general management leadership
positions at American Airlines, Northwest Airlines and America West
Airlines. Schoppert is also a member of the boards of The ODP
Corporation, Big Lots, Inc., and Bremer Financial Corporation.
"Wendy's depth of business and Board experience will offer our
team valuable insights as we continue on our journey of redefining
kidney care," said Javier Rodriguez,
CEO of DaVita Inc.
"I've long admired DaVita's unwavering commitment to connecting
deeply with patients and improving health outcomes," said Ms.
Schoppert. "Joining the Board creates an exciting opportunity to
share my perspective and support DaVita in its mission of being the
provider, partner and employer of choice."
With the addition of Ms. Schoppert, the DaVita Board is
comprised of ten highly qualified directors, with 10% racial/ethnic
and 40% gender diversity. Ms. Schoppert will serve on both the
Audit Committee and the Compliance and Quality Committee of
DaVita's Board.
To learn more about DaVita and its Board of Directors, visit
DaVita.com/About.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on
transforming care delivery to improve quality of life for patients
globally. The company is one of the largest providers of kidney
care services in the U.S. and has been a leader in clinical quality
and innovation for more than 20 years. DaVita cares for patients at
every stage and setting along their kidney health journey—from
slowing the progression of kidney disease to helping to support
transplantation, from acute hospital care to dialysis at home. As
of March 31, 2023, DaVita served approximately 200,100
patients at 2,707 outpatient dialysis centers in the
United States. The company also
operated 351 outpatient dialysis centers in 11 other countries
worldwide. DaVita has reduced hospitalizations, improved mortality,
and worked collaboratively to propel the kidney care industry to
adopt an equitable and high-quality standard of care for all
patients, everywhere. To learn more,
visit DaVita.com/About.
Investor Relations
IR@davita.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/davita-announces-wendy-schoppert-to-join-its-board-of-directors-301876974.html
SOURCE DaVita Inc.